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Abstract
Introduction: This is the first report of the case of a patient with a natural history of dysembryoplastic
neuroepithelial tumor associated with probable sudden unexplained death in epilepsy. These tumors are benign,
arising within the supratentorial cortex. Over 100 cases have been reported in the literature since the first
description by Daumas-Duport in 1988.
Case presentation: A 24- year-old Caucasian woman had a long period of intractable complex partial seizures,
sometimes with tonic-clonic generalization and neuropsychological abnormalities. Magnetic resonance imaging
showed a cortico-subcortical parietal tumor with all the characteristics of these types of tumors. After 14 years of
evolution, our patient died suddenly during sleep.
Conclusion: To the best of our knowledge, this is the first case of probable sudden unexplained death in
symptomatic epilepsy due to dysembryoplastic neuroepithelial tumor with natural history. Early and complete
excision, with functional studies before and during the surgery, leads to better control of seizures, avoiding
neuropsychological changes and the risk of death. Patients with refractory epilepsy should be evaluated for any
sleep disorders and should have complete cardiology assessments including electrocardiographic evaluation of
cardiac rhythm disturbances.
Introduction
Dysembryoplastic neuroepithelial tumor (DNT) is a rare
low-grade, mixed neuronal and glial tumor, usually asso-
ciated with pharmacologically intractable, complex par-
tial or generalized seizures which date from childhood.
DNTs are heterogenous lesions composed of multiple,
mature cell types. Features include a multinodular and
multicystic appearance, the presence of both neuronal
and glial (oligodendrocytic and astrocytic) components
with little if any cytologic atypia, the presence of accom-
panying cortical dysplasia, and the lack of an arcuate
vascular pattern. The prognosis after surgery is favour-
able. Differentiation of DNT from gangliogliomas or
other low grade gliomas is possible using magnetic reso-
nance imaging (MRI) features and is important because
DNT does not recur after epilepsy surgery. Therefore
postoperative radiation and chemotherapy are not
needed, and in infancy and childhood they may be dele-
terious, so the recognition of surgically curable clinico-
pathological entities is mandatory. The presence of
secondary generalized seizures, an extratemporal irrita-
tive zone and a structural lesion in extratemporal
regions correlate with sudden unexplained death in epi-
lepsy (SUDEP). Thus, all efforts should be undertaken
to eliminate this seizure including abstract epilepsy
surgery.
Case presentation
A 24- year-old Caucasian woman was admitted to our
department with refractory epilepsy. Her history
included a normal birth and normal psychomotor devel-
opment. The seizures started at the age of 11, and were
of the complex partial atonic type. The moment of men-
tal decline and change of behavior appeared a few
months after the onset of seizures. Computer tomogra-
phy (CT) showed a left temporoparietal diffuse hypo-
dense area, quite inhomogeneous without mass effect
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any medium, provided the original work is properly cited.(Figure 1, panel A). Cerebral MRI performed four years
later confirmed the diagnosis of brain tumor. Over this
time, the pattern of the seizures changed, becoming par-
tial, complex, sometimes evolving to secondarily gener-
alized seizures, with premenstrual flare-ups in intensity
and frequency. Surgery or brain biopsy were constantly
refused by the patient’sm o t h e r .S h ew a st r e a t e dw i t h
carbamazepine, phenytoin, valproic acid and topiramate
in diverse doses and combinations without effect on sei-
zures, which continued once or several times a day.
On admission to our clinic, 13 years after the disease
onset, neurological examination revealed no positive
findings other than neuropsychological abnormalities.
Mnesic activity, general cognitive index (GCI), vocabu-
lary and operational effectiveness of thinking had
decreased by 35% (mean range) compared to the pre-
vious examination at disease onset.
Biological tests appeared to be normal. A chest X-ray
and cardiology examination were normal. MRI revealed
a 32.3 mm (anteroposterior)×43.1 mm (transverse)×28.3
mm (craniocaudal) multicystic cortico-subcortical parie-
tal lesion, divided by septations, without edema or mass
effect, and no enhancement (Figure 1, panels B, C, D).
As our patient refused to have a cerebral biopsy, we
decided to perform a complementary imaging explora-
tion, which could offer us more details about the tumor.
Tomoscintigraphy (single-photon emission CT) with
Tc99m MIBI indicated no tumor metabolic activity.
Standard electroencephalogram (EEG) showed interictal
abnormalities like spikes and polyspikes. One minute of
hyperventilation activated a tonic-clonic generalized sei-
zure, accompanied by specific EEG recording (Figure 2).
The long history together with the clinical and imaging
data led us to the diagnosis of DNP. One year later, our
patient died during sleep. At that time she was on topir-
amate 400 mg/day in two divided doses, without seizure
control.
Discussion
To the best of our knowledge, this is the first reported
case with probable sudden death in symptomatic epi-
lepsy due to DNT. DNT is a newly-described, patholo-
gically benign tumor, arising within the supratentorial
cortex. Over 100 cases have been reported in the lit-
erature since the first description by Daumas-Duport
in 1988 [1]. The majority of cases are found in the
temporal lobe where they can coexist with mesial tem-
poral sclerosis, followed by the frontal, parietal and
rarely the occipital lobe. From the epidemiologic point
of view, incidence is between six and 35 years old,
with an average of 21.5 years and an equal sex
distribution.
Figure 1 Imaging results. (A) First CT scan show a left temporoparietal diffuse hypodense area, quite inhomogeneous without mass effect. (B-
D) MRI performed 13 years after seizure onset revealed a multicystic cortico-subcortical parietal lesion, without edema, mass effect, and
enhancement.
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cortex, and consists of oligodendrocytes, astrocytes, neu-
rons, and glyconeural elements. This cortical structural
abnormality disrupts normaln e u r o n a lc i r c u i t r ya n d
becomes an epileptogenic focus. Neuronal cells in the
lesion may also secrete neurotransmitters or express
receptors. Neuronal markers (synaptophysin, neuron-
specific enolase) and glial markers (GFAP, S-100) are
positive. Despite benign behavior, it may have a high
MIB-1 labeling index. Aberrant expression of apoptosis-
associated proteins (bcl-2, bcl-x, bax), similar to what
has been previously described in gangliogliomas
(another epilepsy-related, dysplasia-associated tumor),
may play a role in the pathogenesis of DNT [2]. Today,
DNT refers to polymorphic tumors that appear during
embryogenesis. In the revised World Health Organiza-
tion classification, DNTs have been incorporated into
the category of neuronal and mixed neuronoglial tumors
[3]. Non contrast-enhanced CT scans show well-demar-
cated lesions that are hypodense relative to the sur-
rounding brain, sometimes with intratumoral
calcification and multicystic appearance. Routine MRI
sequences reveal a well-demarcated lesion, hypointense
on T1-weighted images, and hyperintense on T2-
weighted images. Edema and mass effect on midline
structures are lacking, although they may be observed in
cases of hemorrhagic complications [4]. The lobular
aspect with presence of septations can sometimes occur
(as in our case). Single-photon emission CT has been
used in limited fashion with DNTs, and this shows
hypoperfusion or poor isotope uptake. MR spectroscopy
allows the determination of certain biochemical proper-
ties of the brain in vivo and reflects the biologic charac-
teristics of benign tumor. The combination of
preoperative positron emission tomographic metabolic
studies with functional brain mapping allows for predic-
tion of tumor type, defines eloquent areas of cortical
function, and improves approach and resection of the
tumors with minimal risk of neurological impairment.
Differential diagnosis includes oligodendrogliomas,
mixed gliomas and gangliogliomas. Treatment options
and prognosis differ significantly between these lesions.
It is important that DNT and glioma be correctly differ-
entiated at diagnosis, because patients with DNT should
not be subjected to potentially harmful adjuvant thera-
pies such as radiation or chemotherapy.
Our diagnosis was based on the characteristic imaging
investigations, the stationary dimensions of the tumor
during a follow-up of 13 years and the clinical expres-
sion of epilepsy unresponsive to treatment. It is true
Figure 2 EEG showing interictal spikes and polyspikes. One minute of hyperventilation activated a tonic-clonic generalized seizure.
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helped to confirm the diagnosis, although this may
sometimes be irrelevant.
Treatment for DNT is surgical resection; however,
there is no cohort of untreated control patients. The
relationship of DNT to the epileptogenic foci can be
determined by extensive interictal and ictal EEG record-
ings. Noninvasive recording and careful mapping show
that a structural lesion is not the source of epileptic
activity. There is little correlation between the lesion
site and epileptogenic foci of the ictal onset zone as well
a st h ei r r i t a t i v ez o n e .S e i z u r ec o n t r o la f t e rs u r g e r yi s
good with 80-90% seizure free. Other authors show that
seizure outcome is not always favorable. Although the
majority of children remain seizure free after surgical
excision of DNTs, a considerable number have recurrent
seizures. Short-term outcome is influenced by older age
at surgery and longer duration of epilepsy. Residual
tumor is a significant risk factor for poor seizure out-
come [5]. DNTs have a benign course, but there are
some reports with malignant transformation. Our
patient was found by her mother in a prone position at
the time of death. At the time she was on topiramate
400 mg/day in two divided doses, without seizure con-
trol. Our patient meets the criteria used in most SUDEP
studies: she had recurrent unprovoked seizures, died
unexpectedly and suddenly while in a reasonable state
of health, during normal and benign circumstances, and
the death was not the direct result of a seizure or status
epilepticus. The probable SUDEP is given because of
lack of autopsy. In 60% of cases, the event was related
to sleep, which might indicate involvement of a sleep-
related event. Our patient was not assessed for any sleep
disorders which may predispose to SUDEP.
The seizures are known to cause central apnea by
direct propagation of the electrical discharge to the
respiratory center. Cardiac dysrhythmias during the
interictal state is another potentially fatal condition
because of chronic autonomic dysfunction, effects of
antiepileptic medication and a common genetic suscept-
ibility [6,7]. Asystole might underlie many of the deaths.
Clinical characteristics of patients with periictal cardiac
abnormalities are very similar to those at greatest risk of
SUDEP. Cardiac arrest can cause secondary cardiopul-
monary arrest [8]. Asphyxiation secondary to an
obstructive cause has been postulated to play a role in
the deaths of patients who were found in a prone posi-
tion at the time of death [9]. Human and animal data
suggest that specific genetic factors might play a role in
some cases. Serotonin might affect respiratory mechan-
isms and may be involved [10]. Prolonged postictal gen-
eralized electroencephalographic suppression, greater
than 50 seconds, appears to identify refractory epilepsy
patients who are at risk of SUDEP [11]. There are some
data suggesting that having an extratemporal focus or
lesion is the main correlate of SUDEP [12].
Our patient presented several risk factors: generalized
seizures, lower age of onset of seizures, duration of sei-
zures longer than 10 years, age between 20 and 40 years
and a poorly controlled disorder. SUDEP incidence rates
vary from 0.35 per 1000 person-years of follow-up in
population based studies to 9.3 per 1000 person-years in
patients with refractory epilepsy [13]. Estimated SUDEP
rates in patients receiving the new anticonvulsant drugs
lamotrigine, gabapentin, topiramate, tiagabine, and zoni-
samide were found to be similar to those in patients
receiving standard anticonvulsant drugs, suggesting that
SUDEP rates reflect population rates and not a specific
drug effect. The Food and Drug Administration require
warning labels on the risk of SUDEP in association with
the use of each of the above-mentioned drugs [14].
Elimination of seizures after surgery reduces mortality
rates in individuals with epilepsy to a level indistinguish-
able from that of the general population [15]. The pub-
lished National Institute for Clinical Excellence
guidelines state that “individuals with epilepsy and their
families and/or carers should be given and have access
to information on SUDEP”.
Conclusion
DNTs are now known to be more frequent in children
and young adults than was previously believed. Early
and complete surgery, with functional studies before
and during the surgery, leads to a good control of sei-
zures, avoiding complications such as hemorrhage,
malignant transformation and neuropsychological
changes, as in our case. Unfortunately, all the studies,
(especially the case series) published so far mention only
the medium term seizure control but do not refer to the
neurological disabilities caused by the surgery. Patients
with refractory epilepsy should have complete sleep dis-
order and cardiology assessments including electrocar-
diogram evaluation of cardiac rhythm disturbances,
which could be performed at the same time as the EEG.
Consent
Written informed consent for publication from the
patient¹s next of kin could not be obtained despite all
reasonable attempts. The case is important to public
health and every effort has been made to protect the
identity of our patient. There is no reason to believe
that our patient’s next of kin would object to
publication.
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